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Tumor relapse after therapy typifies hepatocellular carcinoma (HCC) and is believed to be 
attributable to residual cancer stem cells (CSCs) that survive initial treatment. We have 
previously identified a CSC population derived from HCC that is characterized by the expression 
of the transmembrane glycoprotein, CD133. Despite our growing knowledge of the importance of 
a functional CD133+ liver CSC subset in driving HCC, the regulatory mechanism of CD133 is 
not known. Epigenetic changes are believed to be essential in the control of cancer and stem cells. 
We report here the dynamic epigenetic regulation of the functional liver CSC marker CD133 by 
promoter methylation and miR-142-3p regulation. Unlike in other tumor types, we found DNA 
methylation to only play a minor role in the control of CD133 expression in HCC. More 
importantly, our results revealed that miR-142-3p plays an integral part in the direct targeting of 
CD133. The interaction between the 3’UTR of CD133 and miR-142-3p was identified by in silico 
prediction and substantiated by luciferase reporter analysis. Expression of CD133 was found to be 
inversely correlated with miR-142-3p in a panel of liver cell lines and HCC clinical samples. 
Functional studies with miR-142-3p stably transduced in HCC cells demonstrated a diminished 
ability to self-renew, initiate tumor growth, invade, migrate, induce capillary tube formation in 
endothelial cells and resist standard chemotherapy. Rescue experiments whereby CD133 and 
miR-142-3p is simultaneously overexpressed compensated the deregulated ability of the cells to 
confer these cancer and stem cell-like features. In summary, our findings suggestion promoter 
methylation to only play a minor role in the regulation of CD133 in HCC; and that miR-142-3p 
directly targets CD133 to regulate its ability to confer cancer and stem cell-like features in HCC. 
